Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Guido Tricot

Concepts (548)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
147
2024
2916
9.340
Why?
Hematopoietic Stem Cell Transplantation
28
2024
555
3.730
Why?
Pyrazines
20
2023
187
2.720
Why?
Antineoplastic Combined Chemotherapy Protocols
35
2024
994
2.570
Why?
Boronic Acids
19
2014
182
2.520
Why?
Thalidomide
28
2023
374
2.490
Why?
Transplantation, Autologous
30
2024
462
2.000
Why?
Antineoplastic Agents
30
2020
1175
2.000
Why?
Transplantation Conditioning
9
2019
82
1.510
Why?
Drug Resistance, Neoplasm
17
2020
314
1.500
Why?
Paraproteinemias
8
2018
71
1.310
Why?
Humans
157
2024
49929
1.220
Why?
Neoplastic Stem Cells
5
2020
100
1.210
Why?
Protease Inhibitors
6
2011
58
1.100
Why?
Venous Thrombosis
7
2009
89
1.070
Why?
Melphalan
16
2023
173
1.030
Why?
Stem Cell Transplantation
13
2023
179
1.020
Why?
Angiogenesis Inhibitors
9
2009
182
1.020
Why?
Aged
58
2024
9449
0.980
Why?
Gene Expression Regulation, Neoplastic
13
2020
824
0.960
Why?
Hematopoietic Stem Cell Mobilization
5
2014
56
0.960
Why?
Prognosis
33
2024
1957
0.950
Why?
Middle Aged
60
2024
12293
0.920
Why?
Alkaline Phosphatase
5
2011
94
0.870
Why?
Busulfan
3
2019
19
0.860
Why?
Treatment Outcome
39
2022
5178
0.810
Why?
Plasma Cells
11
2023
221
0.800
Why?
Dexamethasone
16
2024
424
0.760
Why?
Male
68
2024
25454
0.720
Why?
Chromosome Aberrations
9
2008
295
0.670
Why?
Female
64
2024
26576
0.670
Why?
Thromboembolism
3
2009
54
0.670
Why?
Neoplasm Proteins
6
2021
321
0.650
Why?
Chromosomes, Human, Pair 13
6
2008
38
0.620
Why?
Disease-Free Survival
14
2019
450
0.590
Why?
Immunoglobulin Light Chains
3
2016
82
0.580
Why?
Survival Rate
18
2019
905
0.580
Why?
Bone Remodeling
2
2010
149
0.580
Why?
Anticoagulants
5
2009
254
0.580
Why?
Gene Expression Profiling
18
2023
1028
0.570
Why?
Blood Transfusion
1
2018
125
0.570
Why?
Immunologic Factors
5
2012
112
0.560
Why?
Cell Line, Tumor
18
2023
1388
0.540
Why?
Follow-Up Studies
21
2024
2177
0.530
Why?
Receptors, Retinoic Acid
2
2013
22
0.520
Why?
Antineoplastic Agents, Alkylating
7
2008
74
0.520
Why?
Proteasome Inhibitors
6
2018
104
0.510
Why?
IMP Dehydrogenase
2
2006
3
0.510
Why?
Mycophenolic Acid
2
2006
18
0.510
Why?
Clinical Trials as Topic
9
2022
466
0.500
Why?
Adult
38
2024
13356
0.500
Why?
Combined Modality Therapy
13
2008
638
0.490
Why?
Recurrence
16
2018
658
0.480
Why?
Cell Proliferation
15
2020
986
0.480
Why?
Antigens, Neoplasm
5
2007
146
0.470
Why?
Apoptosis
9
2019
1092
0.460
Why?
Up-Regulation
5
2020
446
0.460
Why?
Antibodies, Monoclonal
3
2015
457
0.460
Why?
Retrospective Studies
18
2024
6124
0.450
Why?
Osteogenesis
3
2012
353
0.450
Why?
Animals
30
2024
13100
0.450
Why?
Venous Thromboembolism
3
2011
67
0.450
Why?
Survival Analysis
12
2021
670
0.440
Why?
Signal Transduction
12
2020
1608
0.440
Why?
Disease Progression
12
2019
820
0.440
Why?
Doxorubicin
8
2018
233
0.440
Why?
Bone Diseases
3
2012
97
0.420
Why?
Neoplasms, Second Primary
2
2024
74
0.410
Why?
Thrombosis
4
2012
249
0.410
Why?
Central Nervous System Neoplasms
2
2004
64
0.410
Why?
T-Lymphocytes
10
2024
328
0.410
Why?
Myeloablative Agonists
5
2014
30
0.400
Why?
Bone Marrow
7
2022
351
0.390
Why?
Transplantation, Homologous
6
2004
140
0.390
Why?
Oligopeptides
2
2013
93
0.380
Why?
Osteoblasts
4
2007
451
0.380
Why?
Risk Factors
18
2018
3605
0.380
Why?
Hematopoietic Stem Cells
2
2010
182
0.380
Why?
Meta-Analysis as Topic
2
2015
38
0.360
Why?
Salvage Therapy
9
2012
136
0.360
Why?
Granulocyte Colony-Stimulating Factor
2
2008
60
0.360
Why?
Tumor Microenvironment
3
2024
221
0.360
Why?
Mice
19
2024
5658
0.360
Why?
Bone Marrow Transplantation
5
2007
112
0.350
Why?
Enzyme Inhibitors
2
2019
378
0.350
Why?
Membrane Proteins
4
2017
347
0.350
Why?
Monoclonal Gammopathy of Undetermined Significance
4
2024
111
0.340
Why?
Ultrasonography, Doppler
2
2007
41
0.340
Why?
Remission Induction
10
2008
205
0.340
Why?
Prospective Studies
9
2019
2345
0.330
Why?
Cell Cycle Proteins
2
2021
167
0.330
Why?
Neoplasm, Residual
4
2022
157
0.330
Why?
Myelodysplastic Syndromes
4
2007
79
0.330
Why?
B-Lymphocytes
4
2021
175
0.320
Why?
Waldenstrom Macroglobulinemia
3
2018
40
0.320
Why?
Lymphoma, B-Cell
3
2021
61
0.320
Why?
Immunosuppressive Agents
3
2005
226
0.310
Why?
Neovascularization, Pathologic
1
2009
153
0.310
Why?
Bone Neoplasms
1
2010
178
0.310
Why?
Killer Cells, Natural
4
2024
107
0.300
Why?
Brain Diseases, Metabolic
1
2007
5
0.290
Why?
Aged, 80 and over
11
2019
3138
0.290
Why?
Proteasome Endopeptidase Complex
4
2018
116
0.290
Why?
Dose-Response Relationship, Drug
6
2016
1354
0.290
Why?
Chromosome Deletion
3
2008
138
0.290
Why?
Hyperammonemia
1
2007
20
0.290
Why?
Amyloidosis
2
2007
77
0.280
Why?
Research Design
1
2009
344
0.280
Why?
Farnesyltranstransferase
1
2006
5
0.280
Why?
Thrombophilia
4
2009
18
0.280
Why?
Peripheral Blood Stem Cell Transplantation
4
2014
53
0.280
Why?
Small Molecule Libraries
2
2019
67
0.280
Why?
Hemostasis
1
2007
56
0.280
Why?
Bone and Bones
1
2010
473
0.270
Why?
Sirolimus
1
2006
62
0.270
Why?
Immunotherapy, Adoptive
4
2024
158
0.260
Why?
Gastrointestinal Neoplasms
1
2006
40
0.260
Why?
Cell Survival
8
2018
590
0.260
Why?
Caspases
1
2006
104
0.250
Why?
In Situ Hybridization, Fluorescence
6
2016
256
0.250
Why?
Flow Cytometry
6
2018
470
0.250
Why?
Diploidy
2
2004
26
0.250
Why?
beta 2-Microglobulin
5
2008
38
0.250
Why?
Antibody Formation
1
2005
51
0.240
Why?
Religion
1
2005
62
0.240
Why?
Activated Protein C Resistance
4
2011
10
0.240
Why?
Case-Control Studies
10
2018
1129
0.240
Why?
Enoxaparin
1
2004
27
0.240
Why?
Aneuploidy
1
2004
18
0.240
Why?
Ubiquitination
2
2021
40
0.230
Why?
Attitude to Health
1
2005
190
0.230
Why?
Adaptation, Psychological
1
2005
224
0.230
Why?
Osteolysis
2
2022
75
0.220
Why?
Multivariate Analysis
5
2008
579
0.220
Why?
Cancer Vaccines
3
2010
78
0.220
Why?
Cisplatin
6
2009
275
0.220
Why?
Randomized Controlled Trials as Topic
4
2012
550
0.220
Why?
Cell Communication
2
2006
69
0.220
Why?
Pyrimidines
3
2015
192
0.210
Why?
Blood Coagulation
1
2003
58
0.210
Why?
Mice, Inbred NOD
6
2020
94
0.210
Why?
Antigens, CD34
1
2003
65
0.210
Why?
Critical Illness
1
2005
297
0.210
Why?
Cytogenetic Analysis
6
2007
80
0.210
Why?
Graft vs Host Disease
5
2010
73
0.210
Why?
Parathyroid Hormone
3
2010
147
0.200
Why?
Kidney
1
2007
672
0.200
Why?
Cyclophosphamide
4
2003
163
0.200
Why?
Leukemia, Myeloid
1
2002
42
0.200
Why?
STAT3 Transcription Factor
4
2015
80
0.200
Why?
Bone Resorption
2
2022
297
0.200
Why?
Chromosome Disorders
1
2002
35
0.200
Why?
Etoposide
5
2009
71
0.190
Why?
Time Factors
9
2016
2891
0.190
Why?
Hypothyroidism
1
2002
54
0.190
Why?
Cyclin-Dependent Kinase Inhibitor p21
2
2015
67
0.190
Why?
Logistic Models
5
2018
896
0.190
Why?
Chromosomes, Human, Pair 1
3
2006
92
0.190
Why?
Antibodies, Bispecific
1
2022
70
0.190
Why?
Neoplasm Recurrence, Local
4
2024
626
0.180
Why?
Cytotoxicity, Immunologic
3
2012
56
0.170
Why?
Neoplasms
2
2009
1234
0.170
Why?
Xenograft Model Antitumor Assays
5
2019
212
0.170
Why?
DNA-Binding Proteins
2
2020
424
0.170
Why?
Glucuronidase
2
2018
48
0.170
Why?
Predictive Value of Tests
5
2009
907
0.170
Why?
Proto-Oncogene Proteins c-bcl-2
2
2013
126
0.160
Why?
Hematologic Neoplasms
2
2016
98
0.160
Why?
Syndecan-1
3
2017
72
0.160
Why?
Cytokines
4
2007
607
0.160
Why?
Osteoclasts
4
2022
424
0.160
Why?
Kaplan-Meier Estimate
6
2015
463
0.160
Why?
Healthcare Disparities
1
2022
282
0.160
Why?
Hydrocarbons, Aromatic
1
2018
2
0.160
Why?
Solvents
1
2018
29
0.160
Why?
Drug Tolerance
1
2018
59
0.160
Why?
Pyridines
1
2019
133
0.160
Why?
T-Lymphocytes, Cytotoxic
3
2010
65
0.160
Why?
Jehovah's Witnesses
1
2018
6
0.160
Why?
Dendritic Cells
3
2010
133
0.150
Why?
Vincristine
3
2003
84
0.150
Why?
Cell Differentiation
4
2022
649
0.150
Why?
Platelet Count
3
2008
64
0.150
Why?
CDC2-CDC28 Kinases
2
2015
11
0.150
Why?
Risk Assessment
5
2023
1255
0.150
Why?
Iron
2
2017
123
0.150
Why?
Occupational Diseases
1
2018
82
0.150
Why?
Arsenicals
2
2010
14
0.140
Why?
Pyruvate Kinase
1
2017
7
0.140
Why?
Ascorbic Acid
1
2017
22
0.140
Why?
Oxides
2
2010
18
0.140
Why?
Occupational Exposure
1
2018
112
0.140
Why?
Interleukin-6
2
2018
265
0.140
Why?
Drug Combinations
1
2017
126
0.140
Why?
Mice, SCID
5
2018
173
0.140
Why?
Anthropometry
1
2017
91
0.140
Why?
RNA Splicing
1
2017
37
0.140
Why?
Glycolysis
1
2017
68
0.140
Why?
Immunoglobulin lambda-Chains
1
2016
14
0.130
Why?
Immunotherapy
4
2006
235
0.130
Why?
Transcription Factors
1
2020
565
0.130
Why?
Factor V
3
2011
11
0.130
Why?
Immunoglobulin kappa-Chains
1
2016
20
0.130
Why?
MicroRNAs
1
2020
347
0.130
Why?
Incidence
3
2009
986
0.130
Why?
Fibrinolytic Agents
2
2007
125
0.130
Why?
Tumor Cells, Cultured
6
2019
462
0.130
Why?
Leukocytes, Mononuclear
2
2014
112
0.130
Why?
Reproductive History
1
2015
4
0.130
Why?
Oncolytic Virotherapy
1
2015
18
0.130
Why?
Hormone Replacement Therapy
1
2015
22
0.130
Why?
Cyclopentanes
1
2015
10
0.130
Why?
Cell Adhesion Molecules
1
2015
87
0.130
Why?
Hemorrhage
2
2007
194
0.130
Why?
Ubiquitins
1
2015
39
0.130
Why?
Postmenopause
1
2015
76
0.120
Why?
Cation Transport Proteins
1
2015
27
0.120
Why?
Receptors, Cell Surface
1
2015
120
0.120
Why?
Aldehyde Dehydrogenase
1
2014
26
0.120
Why?
NF-kappa B
3
2018
315
0.120
Why?
Drug Monitoring
1
2015
78
0.120
Why?
Intestines
1
2016
169
0.120
Why?
Leukapheresis
1
2014
15
0.120
Why?
Protein-Tyrosine Kinases
1
2015
95
0.120
Why?
Transplantation Chimera
3
2003
15
0.120
Why?
Translocation, Genetic
3
2005
263
0.120
Why?
Myeloma Proteins
2
2020
24
0.110
Why?
Antibodies
2
2024
151
0.110
Why?
Gene Deletion
3
2004
267
0.110
Why?
Body Mass Index
1
2017
648
0.110
Why?
Polymorphism, Single Nucleotide
1
2016
483
0.110
Why?
Receptor, Parathyroid Hormone, Type 1
1
2013
24
0.110
Why?
Veratrum Alkaloids
1
2013
5
0.110
Why?
Multidrug Resistance-Associated Proteins
1
2013
16
0.110
Why?
Isoxazoles
1
2013
14
0.110
Why?
Biopsy
2
2006
591
0.110
Why?
Hedgehog Proteins
1
2013
33
0.110
Why?
Sulfones
1
2013
24
0.110
Why?
Cystatin M
2
2024
19
0.110
Why?
Itraconazole
1
2013
41
0.110
Why?
Genetic Predisposition to Disease
1
2016
508
0.110
Why?
Metaphase
3
2008
45
0.110
Why?
Carrier Proteins
2
2017
302
0.110
Why?
Intercellular Adhesion Molecule-1
1
2013
61
0.110
Why?
B-Cell Maturation Antigen
2
2024
88
0.110
Why?
Wnt Proteins
1
2013
100
0.110
Why?
Renal Insufficiency
3
2009
107
0.100
Why?
Risk
2
2011
314
0.100
Why?
Infusions, Intravenous
2
2003
212
0.100
Why?
Viremia
1
2012
22
0.100
Why?
Drug Delivery Systems
2
2005
143
0.100
Why?
Chromosomes, Human, Pair 11
2
2002
54
0.100
Why?
Cytomegalovirus Infections
1
2012
35
0.100
Why?
Clinical Trials, Phase II as Topic
1
2012
46
0.100
Why?
Radiopharmaceuticals
2
2021
205
0.100
Why?
Clinical Trials, Phase III as Topic
1
2012
46
0.100
Why?
Receptors, KIR
2
2008
13
0.100
Why?
Phosphorylation
2
2020
526
0.100
Why?
Fluorodeoxyglucose F18
2
2021
191
0.100
Why?
Medical Oncology
1
2012
95
0.100
Why?
Alcohol Drinking
1
2013
221
0.100
Why?
Reoperation
2
2004
454
0.100
Why?
Ligands
2
2009
203
0.100
Why?
Inflammation
1
2016
603
0.100
Why?
Drug Evaluation, Preclinical
1
2012
145
0.100
Why?
Age Factors
3
2005
1092
0.090
Why?
Receptors, TNF-Related Apoptosis-Inducing Ligand
1
2010
6
0.090
Why?
Smoking
1
2014
506
0.090
Why?
Tretinoin
2
2009
53
0.090
Why?
TNF-Related Apoptosis-Inducing Ligand
1
2010
20
0.090
Why?
Recombinant Proteins
2
2010
482
0.090
Why?
Janus Kinase 1
1
2010
16
0.090
Why?
Antineoplastic Agents, Hormonal
2
2007
49
0.090
Why?
Macrophages
1
2013
361
0.090
Why?
MAP Kinase Kinase 1
1
2010
23
0.090
Why?
Cyclin-Dependent Kinases
1
2010
26
0.090
Why?
Down-Regulation
2
2010
342
0.090
Why?
Authorship
1
2010
12
0.090
Why?
Extracellular Signal-Regulated MAP Kinases
1
2010
81
0.090
Why?
Neoplasm Staging
3
2015
749
0.090
Why?
Conflict of Interest
1
2010
25
0.090
Why?
Drug Industry
1
2010
38
0.090
Why?
Bone Density Conservation Agents
1
2010
74
0.090
Why?
Disclosure
1
2010
38
0.080
Why?
Diphosphonates
1
2010
90
0.080
Why?
Mice, Transgenic
3
2021
543
0.080
Why?
Chromosome Banding
2
2006
24
0.080
Why?
Leukocyte Count
2
2014
71
0.080
Why?
Plasmacytoma
2
2011
39
0.080
Why?
Periodicals as Topic
1
2010
57
0.080
Why?
Maximum Tolerated Dose
2
2009
38
0.080
Why?
Cell Cycle
2
2010
226
0.080
Why?
Oligonucleotide Array Sequence Analysis
5
2014
409
0.080
Why?
Magnetic Resonance Imaging
3
2007
1526
0.080
Why?
Cryoglobulinemia
1
2008
12
0.080
Why?
Blotting, Western
3
2015
587
0.080
Why?
Vascular Endothelial Growth Factor A
1
2009
183
0.080
Why?
Cytogenetics
1
2008
23
0.080
Why?
Prednisone
2
2009
100
0.080
Why?
Polyethylene Glycols
1
2008
85
0.080
Why?
Sulfonamides
1
2009
125
0.080
Why?
Pulmonary Embolism
1
2009
98
0.080
Why?
Hemoglobins
1
2008
106
0.080
Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2015
579
0.080
Why?
Neutrophils
2
2014
148
0.070
Why?
Immunophenotyping
2
2007
109
0.070
Why?
Adoptive Transfer
1
2007
30
0.070
Why?
Heparin, Low-Molecular-Weight
1
2007
20
0.070
Why?
Histocompatibility Antigens Class I
1
2007
44
0.070
Why?
CD8-Positive T-Lymphocytes
2
2024
124
0.070
Why?
Phlebography
1
2007
60
0.070
Why?
Fibrinolysis
1
2007
5
0.070
Why?
Ammonia
1
2007
72
0.070
Why?
Blood Coagulation Factors
1
2007
17
0.070
Why?
Serum Albumin
2
2008
58
0.070
Why?
Chi-Square Distribution
1
2007
275
0.070
Why?
Biomedical Research
1
2010
241
0.070
Why?
Brain
2
2007
1310
0.070
Why?
Cell Membrane
1
2007
249
0.070
Why?
Osteoprotegerin
1
2006
52
0.070
Why?
Drug Administration Schedule
2
2006
369
0.070
Why?
Models, Genetic
1
2006
174
0.070
Why?
Guanosine
1
2006
6
0.070
Why?
Antibiotics, Antineoplastic
1
2006
77
0.070
Why?
Sex Factors
3
2016
692
0.060
Why?
Femur Head Necrosis
1
2005
18
0.060
Why?
Renal Dialysis
1
2007
170
0.060
Why?
Neovascularization, Physiologic
1
2005
68
0.060
Why?
Survivors
1
2006
120
0.060
Why?
Guanosine Triphosphate
1
2004
20
0.060
Why?
Karyotyping
1
2005
82
0.060
Why?
Gene Duplication
1
2005
15
0.060
Why?
Tissue Donors
2
2003
111
0.060
Why?
Kidney Transplantation
1
2007
175
0.060
Why?
Oncogene Proteins, Fusion
1
2005
59
0.060
Why?
Proteolysis
2
2015
93
0.060
Why?
Thrombophlebitis
1
2004
24
0.060
Why?
Genomic Instability
1
2005
91
0.060
Why?
Tomography, Emission-Computed
1
2004
53
0.060
Why?
Ferritins
1
2024
30
0.060
Why?
RNA Interference
2
2015
178
0.060
Why?
Myeloid Progenitor Cells
1
2023
17
0.060
Why?
X-Ray Microtomography
1
2024
78
0.060
Why?
Chromatography, High Pressure Liquid
1
2004
326
0.060
Why?
Patient Selection
1
2005
254
0.050
Why?
Discitis
1
2003
9
0.050
Why?
Stem Cell Factor
1
2003
7
0.050
Why?
Anxiety
1
2005
273
0.050
Why?
Confidence Intervals
1
2003
155
0.050
Why?
Neoplastic Cells, Circulating
1
2004
74
0.050
Why?
Lymphocyte Transfusion
1
2003
10
0.050
Why?
Probability
1
2003
163
0.050
Why?
Interferons
1
2002
38
0.050
Why?
TNF Receptor-Associated Factor 3
1
2022
13
0.050
Why?
Cell Count
1
2003
147
0.050
Why?
Cyclosporine
1
2003
65
0.050
Why?
Drug Therapy, Combination
2
2017
380
0.050
Why?
Geography
1
2022
61
0.050
Why?
Tacrolimus
1
2003
57
0.050
Why?
Thyroid Function Tests
1
2002
24
0.050
Why?
Blood Group Incompatibility
1
2002
5
0.050
Why?
Stromal Cells
1
2002
72
0.050
Why?
Administration, Oral
1
2003
433
0.050
Why?
ABO Blood-Group System
1
2002
15
0.050
Why?
Leukemia, Promyelocytic, Acute
1
2002
10
0.050
Why?
Thyrotropin
1
2002
47
0.050
Why?
Drug Interactions
1
2002
209
0.050
Why?
Fatal Outcome
1
2002
194
0.050
Why?
Cell Division
1
2002
294
0.050
Why?
Chromosome Mapping
3
2006
158
0.050
Why?
Genomics
1
2023
284
0.050
Why?
RANK Ligand
1
2022
179
0.050
Why?
Graft Survival
1
2002
153
0.050
Why?
Acute Disease
1
2002
367
0.050
Why?
Cells, Cultured
1
2005
1587
0.050
Why?
Cluster Analysis
3
2006
233
0.050
Why?
Young Adult
3
2015
4031
0.050
Why?
Tomography, X-Ray Computed
1
2006
1153
0.050
Why?
Depression
1
2005
571
0.040
Why?
Neoplasm Transplantation
1
2020
84
0.040
Why?
Pain
1
2003
374
0.040
Why?
Odds Ratio
2
2016
548
0.040
Why?
3' Untranslated Regions
1
2020
53
0.040
Why?
Postoperative Complications
1
2007
1018
0.040
Why?
Staphylococcal Infections
1
2003
269
0.040
Why?
Positron-Emission Tomography
1
2021
288
0.040
Why?
Crystallography, X-Ray
1
2019
148
0.040
Why?
Antigens, CD
2
2015
215
0.040
Why?
Protein Conformation
1
2019
165
0.040
Why?
Mice, Nude
1
2019
252
0.040
Why?
Mice, Inbred BALB C
1
2019
296
0.040
Why?
Bone Marrow Cells
2
2015
190
0.040
Why?
Coculture Techniques
2
2012
143
0.040
Why?
Receptors, Interleukin-6
1
2018
22
0.040
Why?
Antigens, CD19
1
2018
26
0.040
Why?
Drug Resistance
1
2018
64
0.040
Why?
Microarray Analysis
1
2018
73
0.040
Why?
Disease Management
1
2020
175
0.040
Why?
Protein Stability
1
2018
42
0.040
Why?
Interferon-gamma
2
2010
176
0.040
Why?
Gene Knockdown Techniques
1
2018
106
0.040
Why?
Epidemiologic Methods
2
2008
49
0.040
Why?
Aerobiosis
1
2017
14
0.040
Why?
Cross-Sectional Studies
1
2022
1576
0.040
Why?
Microfilament Proteins
1
2017
42
0.040
Why?
Thyroid Hormones
1
2017
18
0.040
Why?
HLA-A Antigens
2
2007
10
0.040
Why?
Calcium-Binding Proteins
1
2017
54
0.030
Why?
Transplantation, Heterologous
1
2017
75
0.030
Why?
Polycomb Repressive Complex 1
1
2016
3
0.030
Why?
Vaccination
2
2010
275
0.030
Why?
Transmembrane Activator and CAML Interactor Protein
1
2016
6
0.030
Why?
Proto-Oncogene Proteins c-myc
1
2017
50
0.030
Why?
Genetic Loci
1
2016
44
0.030
Why?
Protein Binding
1
2018
656
0.030
Why?
Antibodies, Neoplasm
2
2006
28
0.030
Why?
Mice, Inbred ICR
1
2016
22
0.030
Why?
Mice, Knockout
1
2018
835
0.030
Why?
Microscopy, Electron, Transmission
1
2015
75
0.030
Why?
Reoviridae
1
2015
25
0.030
Why?
Genome-Wide Association Study
1
2016
163
0.030
Why?
Tumor Burden
1
2016
131
0.030
Why?
ras Proteins
1
2015
65
0.030
Why?
Receptors, Transferrin
1
2015
16
0.030
Why?
Repressor Proteins
1
2016
149
0.030
Why?
RNA, Messenger
2
2010
1099
0.030
Why?
Side-Population Cells
1
2015
3
0.030
Why?
Disease Models, Animal
2
2013
1411
0.030
Why?
Lentivirus
1
2015
17
0.030
Why?
Retinal Dehydrogenase
1
2014
11
0.030
Why?
Models, Biological
1
2018
719
0.030
Why?
Molecular Targeted Therapy
1
2016
121
0.030
Why?
Adenine
1
2015
31
0.030
Why?
Family
1
2016
177
0.030
Why?
Reactive Oxygen Species
1
2017
405
0.030
Why?
Cyclin B
1
2014
5
0.030
Why?
G2 Phase Cell Cycle Checkpoints
1
2014
8
0.030
Why?
CDC2 Protein Kinase
1
2014
17
0.030
Why?
Portraits as Topic
1
2014
2
0.030
Why?
Cell Lineage
1
2014
83
0.030
Why?
Mitosis
1
2014
88
0.030
Why?
Drug Synergism
1
2014
152
0.030
Why?
beta Catenin
1
2015
101
0.030
Why?
Piperidines
1
2015
96
0.030
Why?
Drug Screening Assays, Antitumor
1
2014
131
0.030
Why?
Pyrazoles
1
2015
111
0.030
Why?
Cell Movement
1
2015
245
0.030
Why?
Proportional Hazards Models
2
2006
404
0.030
Why?
Patient Safety
1
2014
102
0.030
Why?
Peptide Library
1
2013
16
0.030
Why?
Receptors, IgG
1
2013
22
0.030
Why?
Adolescent
2
2014
6417
0.030
Why?
Epitopes
1
2013
59
0.030
Why?
Chromosomal Instability
1
2013
16
0.030
Why?
Membrane Glycoproteins
2
2006
244
0.030
Why?
Protein Kinase Inhibitors
1
2014
205
0.030
Why?
Antibodies, Monoclonal, Murine-Derived
1
2012
47
0.030
Why?
Immunoglobulin M
1
2012
58
0.030
Why?
Interleukin Receptor Common gamma Subunit
1
2012
8
0.030
Why?
NK Cell Lectin-Like Receptor Subfamily K
1
2012
9
0.030
Why?
Cytomegalovirus
1
2012
27
0.030
Why?
Viral Load
1
2012
76
0.020
Why?
Virus Activation
1
2012
35
0.020
Why?
Peripheral Nervous System Diseases
1
2012
57
0.020
Why?
Interleukin-2
1
2012
70
0.020
Why?
Immunoenzyme Techniques
1
2012
141
0.020
Why?
Arkansas
2
2008
1990
0.020
Why?
Viper Venoms
1
2011
7
0.020
Why?
Asymptomatic Diseases
1
2011
36
0.020
Why?
Protein C
1
2011
18
0.020
Why?
Lymphocyte Activation
1
2012
171
0.020
Why?
Neoadjuvant Therapy
1
2012
118
0.020
Why?
Chemotherapy, Adjuvant
1
2011
121
0.020
Why?
Interferon Regulatory Factor-1
1
2010
14
0.020
Why?
Cell Growth Processes
1
2010
22
0.020
Why?
Antiviral Agents
1
2012
168
0.020
Why?
Immunoglobulin Idiotypes
1
2010
5
0.020
Why?
CD40 Ligand
1
2010
14
0.020
Why?
Hypersensitivity, Delayed
1
2010
19
0.020
Why?
Interleukin-4
1
2010
44
0.020
Why?
Immunity, Cellular
1
2010
69
0.020
Why?
Adjuvants, Immunologic
1
2010
51
0.020
Why?
Diagnosis, Differential
2
2004
1037
0.020
Why?
Mutation
1
2015
1292
0.020
Why?
Physician's Role
1
2010
48
0.020
Why?
RNA, Small Interfering
1
2010
210
0.020
Why?
Education, Medical, Continuing
1
2010
68
0.020
Why?
Practice Guidelines as Topic
1
2012
458
0.020
Why?
Hyperhomocysteinemia
1
2009
29
0.020
Why?
Protein Isoforms
1
2009
118
0.020
Why?
Indazoles
1
2009
44
0.020
Why?
Algorithms
1
2012
613
0.020
Why?
Cytotoxicity Tests, Immunologic
1
2008
27
0.020
Why?
Safety
1
2009
77
0.020
Why?
Vasculitis
1
2008
29
0.020
Why?
Ploidies
1
2008
10
0.020
Why?
Haplotypes
1
2008
83
0.020
Why?
Double-Blind Method
1
2009
679
0.020
Why?
Twins
1
2007
21
0.020
Why?
Age Distribution
1
2007
169
0.020
Why?
C-Reactive Protein
1
2008
143
0.020
Why?
Blood Proteins
1
2007
77
0.020
Why?
Creatinine
1
2007
140
0.020
Why?
Multigene Family
1
2006
56
0.020
Why?
Partial Thromboplastin Time
1
2006
12
0.020
Why?
Cyclin D
1
2006
18
0.020
Why?
Syndecans
1
2006
34
0.020
Why?
Heterozygote
1
2006
81
0.020
Why?
Cyclins
1
2006
38
0.020
Why?
RNA, Neoplasm
1
2006
45
0.020
Why?
Proteoglycans
1
2006
81
0.020
Why?
Amiloride
1
2005
8
0.020
Why?
HLA-A2 Antigen
1
2005
11
0.020
Why?
Leukemia, Myeloid, Acute
1
2007
179
0.020
Why?
Transduction, Genetic
1
2005
45
0.020
Why?
Cell Line
1
2008
1010
0.020
Why?
Radiography
1
2007
485
0.020
Why?
Data Interpretation, Statistical
1
2006
159
0.020
Why?
Neoplasms, Experimental
1
2006
111
0.020
Why?
Interferon-alpha
1
2005
48
0.020
Why?
Sensitivity and Specificity
1
2007
858
0.020
Why?
Monocytes
1
2005
131
0.020
Why?
Databases, Factual
1
2007
660
0.010
Why?
Clone Cells
1
2004
78
0.010
Why?
Antibodies, Monoclonal, Humanized
1
2005
223
0.010
Why?
Monosomy
1
2003
5
0.010
Why?
Trisomy
1
2003
31
0.010
Why?
Fibroblasts
1
2005
352
0.010
Why?
History, 21st Century
1
2003
56
0.010
Why?
History, 20th Century
1
2003
95
0.010
Why?
Interphase
1
2003
13
0.010
Why?
Plasmapheresis
1
2003
11
0.010
Why?
Back Pain
1
2003
38
0.010
Why?
United States
1
2013
4883
0.010
Why?
Pore Forming Cytotoxic Proteins
1
2002
9
0.010
Why?
Perforin
1
2002
11
0.010
Why?
Cohort Studies
1
2006
1403
0.010
Why?
Anemia
1
2003
66
0.010
Why?
Antigen Presentation
1
2002
25
0.010
Why?
Red-Cell Aplasia, Pure
1
2002
7
0.010
Why?
Prevalence
1
2005
956
0.010
Why?
Quality Assurance, Health Care
1
2003
149
0.010
Why?
Erythrocyte Transfusion
1
2002
50
0.010
Why?
Cell Culture Techniques
1
2002
97
0.010
Why?
DNA, Neoplasm
1
2002
145
0.010
Why?
Graft Rejection
1
2002
168
0.010
Why?
Kidney Diseases
1
2003
211
0.010
Why?
Anti-Bacterial Agents
1
2003
742
0.010
Why?
Tricot's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description